Publication | Closed Access

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

Metastatic Prostate CancerUrologyOncologyGenitourinary CancerEnzalutamide Versus BicalutamideMedicineClinical TrialsPharmacotherapyCancer TreatmentProstatic DiseasePharmacology